Assessment of health claims on retail packaged food products sold in Trinidad and Tobago in respect to omega-3 fatty acids and cardiovascular diseases
Loading...
Date
2018
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Health claims are very visible today more than ever, as there is an increasing quest for optimal health. This research paper aims to generate information regarding to: (1) whether or not food products sold in Trinidad and Tobago comply with food labeling laws and regulations of their respective countries with reverence to health claims made pertaining to omega-3 fatty acids and (2) the level of awareness, knowledge and purchasing behaviour of consumers on omega-3 fatty acids foods and their benefits pertaining to Cardiovascular Diseases (CVDs). One hundred and twelve (112) products were identified to be fortified with omega-3 fatty acids, however only 1.8% carried true health claims. Data collected from n=171 participants at 16 retail outlets using an online data survey application revealed that middle aged adults (35-44 years) were the majority of the participants with 42.9% (76% females and 24% males). These participants were of mixed ethnicity (40.4%), attained tertiary level education (80.1%), were aware of the nutrient omega-3 fatty acids (97%) and had some knowledge about this nutrient (78%). They also bought foods containing this nutrient (63%) such as fish or fish oils (84%) and consumed them daily (38%). Results showed that knowledge, gender, age and education held no statistical significance on the variables of purchasing, perception and reading of food labels pertaining to omega-3 fatty acids products. The study concluded that persuasive and true health claims maybe a key factor in the successful development, promotion and creation of demands for foods fortified with omega-3 fatty acids, as most consumers are customary food label readers. Thus generating an immense opportunity for omega-3 fatty acids fortified food products to be used as a primary and or secondary treatment of CVDs in Trinidad and Tobago, consequently reducing annual deaths and estimated cost in the management of such diseases